{"nct_id":"NCT05567159","title":"A Study of Donanemab (LY3002813) in Healthy Participants","status":"COMPLETED","status_verified_date":"2024-07-01","start_date":"2022-10-04","start_date_type":"ACTUAL","primary_completion_date":"2023-07-14","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}